ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $361K of Zentalis Pharmaceuticals, Inc.
Sold$360,775
$50.19Price
7,188Shares
−2%Stake
What ZNTL did after the filing
- The stock from Tue, Feb 15 open, $51.69
- −11.8%
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Mar 30 close.
Traded Mon, Feb 14. Filed Mon, Feb 14, 4:09 PM ET, after the close. Returns use the Feb 15 open and the Mar 30 close. Not investment advice.